Tela Bio slumps after Q4 miss as Piper Sandler downgrades

Stock Information for TELA Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TELA Bio Inc.

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
TELA Bio Appoints Jeffrey Blizard as President
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Reports First Quarter 2025 Financial Results
TELA Bio to Announce First Quarter 2025 Financial Results
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.